What is Nano-drug Market Scope?
Nanoscale technology is at present very widely used in medicine, wherein the manipulations are carried out at the molecular level, thereby taking advantage of the novel properties of a material. The main requirement of this area of medicine is to improve treatment delivery and health outcomes. Nanotechnology drug delivery is the use of nanoscale materials and technologies for healthcare in drug delivery to improve the effectiveness of the drug. Nano drugs are a revolutionary and ubiquitous science of the 21st century; a nano-drug is the application of nanotechnology in the medical field, which has the potential to significantly change the course of the diagnosis and treatment of various life-threatening diseases. A nano-drug is basically the application of nanotechnology to medicines, and they are thought to have a huge impact on public health. The interest in nanopharmaceuticals for treatment and diagnosis is clearly reflected in a large number of high-quality research publications and patents that are granted each year. It also sheds light on the current scale-up, market size, and application of nano drugs, including future challenges.
The Nano-drug market study is being classified by Type (Nanoparticles [Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & polymer-drug conjugates, Hydrogel nanoparticles, Dendrimers, Inorganic nanoparticles], Nanoshells, Nanotubes and Nanodevices), by Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective and Other) and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Nano-drug market throughout the predicted period.
Merck & Co. (United States), Pfizer (United States), Novartis (Switzerland), Abbott Laboratories (United States), GlaxoSmithKline (United Kingdom), Roche Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (United States), AstraZeneca (United Kingdom), Johnson & Johnson (United States), Celgene (United States), Novavax (United States), Stryker Corporation (United States), Gilead Sciences (United States), Samyang Biopharm (South Korea), Kaken Pharmaceutical (Japan), Selecta Biosciences (United States) and Par Pharmaceutical, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cerulean Pharma, Inc. (United States), Navidea Biopharmaceuticals, Inc. (United States) and Chongqing LUMMY Pharmaceutical Co., Ltd. (China).
Analyst at AMA have segmented the market study of Global Nano-drug market by Type, Application and Region.
On the basis of geography, the market of Nano-drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In November 2015, Ablynx and Novo Nordisk signed a global collaboration and license agreement for the development and discovery of innovative drugs with multispecific nanobodies. This strategic partnership is expected to increase net annual sales of the products and drive market growth.
Influencing Market Trend
- Growing Preference for Personalized Medicines
- Development of Novel Nanotechnology-Based Drugs and Therapies
- Increasing Prevalence of Chronic Diseases and Illnesses
- A Rise in the Diagnosis and Monitoring of the Effects of Drugs on an Unprecedented Short Timescale
- Increasing Advancements in Nanoscale Technologies
- The Growing Need To Develop Therapies That Have Fewer Side Effects and That Are More Cost-Effective Than Traditional Therapies
- Stringent Regulations for the Mechanism Approval
- The Cost of Nanotechnology Drug Delivery Medicine
Key Target AudienceProviders of Nano-drug, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.